Synthetic RNA-based agonists of TLR7
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 19, 2012
Grant Date -
Aug 26, 2010
app pub date -
Feb 10, 2010
filing date -
Feb 10, 2009
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to the therapeutic use of stabilized oligoribonucleotides as immune modulatory agents for immune therapy applications. Specifically, the invention provides RNA-based oligoribonucleotides with improved nuclease and RNase stability and that selectively induce immune modulatory activity through TLR7.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully